| Catalog Number |
816047100 |
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
03/13/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This is our combined initial and final report on this incident.
|
| |
|
Event or Problem Description
|
|
The customer reported a weak false positive reaction of biotestcell-a2 with the anti-a1 lectin reagent of a competitor.The customer provided a sample of the allegedly defective product biotestcell-a2 for investigational testing and also the anti-a1 reagent.Our quality control laboratory tested the complaint sample as well as their retention sample of biotestcell a2 with the anti-a1 lectin reagent and could confirm the customer´s finding: the supposedly defective product yielded a weak false positive reaction.Additionally the complaint and the retention sample of biotestcell-a2 were tested with seraclone anti-a1 and yielded correctly negative reactions.The weak false positive reactions were only observed with the anti-a1 lectin reagent of a competitor.Based on this false positive reaction we initiated further actions.A review of the batch record documentation showed no irregularities which might have negative influences on the quality of the allegedly defective lot.
|
| |
|
Search Alerts/Recalls
|